Fund Holdings — AIGH Capital Management LLC

Total Portfolio Value:
$1.10B
Total Bought:
$530.37M
Total Sold:
$424.18M
Net Transaction:
+$106.20M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Sandisk Corporation(SNDK)200,000149,000-51,000$127.07M$338.79M30.67%+$211.72M
MaxLinear, Inc.(MXL)0818,000+818,000$0$104.73M9.48%+$104.73M
Intel Corporation(INTC)0623,500+623,500$0$87.06M7.88%+$87.06M
Digital Turbine, Inc.(APPS)4,895,7726,548,450+1,652,678$14.10M$84.48M7.65%+$70.38M
Silicon Motion Technology CorporationADR(SIMO)200,000144,000-56,000$22.46M$48.00M4.35%+$25.54M
Clearfield, Inc.(CLFD)01,008,469+1,008,469$0$40.13M3.63%+$40.13M
Methode Electronics, Inc.(MEI)01,678,409+1,678,409$0$31.84M2.88%+$31.84M
Amtech Sys IncCOM PAR 0 01N01,252,000+1,252,000$0$28.90M2.62%+$28.90M
Fennec Pharmaceuticals Inc.(FENC)1,981,5012,486,038+504,537$12.19M$26.72M2.42%+$14.54M
Kyverna Therapeutics, Inc.(KYTX)2,000,0002,795,797+795,797$17.26M$24.91M2.26%+$7.65M
Nyxoah S ASHS
SHS
014,534,880+14,534,880$0$24.56M2.22%+$24.56M
Personalis, Inc.(PSNL)2,900,0001,715,000-1,185,000$18.47M$22.98M2.08%+$4.51M
SOPHiA GENETICS SA(SOPH)03,954,194+3,954,194$0$22.82M2.07%+$22.82M
3D Systems Corporation(DDD)07,271,000+7,271,000$0$21.96M1.99%+$21.96M
Vuzix Corporation(VUZI)3,295,7546,745,667+3,449,913$7.61M$19.56M1.77%+$11.95M
Abeona Therapeutics Inc.(ABEO)3,100,0002,987,000-113,000$13.89M$18.46M1.67%+$4.57M
Ardelyx Inc03,200,000+3,200,000$0$16.32M1.48%+$16.32M
Biodesix, Inc.(BDSX)758,328678,328-80,000$11.00M$15.30M1.38%+$4.30M
Spruce Biosciences Inc0250,000+250,000$0$13.50M1.22%+$13.50M
Castle Biosciences, Inc.(CSTL)590,601545,101-45,500$14.50M$13.00M1.18%-$1.50M
Vanda Pharmaceuticals Inc.(VNDA)2,750,0002,044,169-705,831$19.00M$12.51M1.13%-$6.49M
Pelthos Therapeutics Inc.(PTHS)0329,098+329,098$0$9.30M0.84%+$9.30M
PolyPid Ltd.(PYPD)1,593,5871,504,741-88,846$6.98M$7.64M0.69%+$664.2K
Verastem, Inc.(VSTM)2,000,0001,927,000-73,000$10.60M$7.36M0.67%-$3.24M
Broadwind, Inc.(BWEN)01,156,000+1,156,000$0$5.58M0.51%+$5.58M
Aeye IncCL A03,855,000+3,855,000$0$5.55M0.50%+$5.55M
OrthoPediatrics Corp.(KIDS)0269,765+269,765$0$5.16M0.47%+$5.16M
Apyx Medical Corporation(APYX)1,104,9701,128,343+23,373$4.08M$5.07M0.46%+$988.9K
Ideal Power Inc.(IPWR)1,181,696894,731-286,965$3.34M$4.80M0.43%+$1.45M
Talphera, Inc.(TLPH)4,661,5024,601,502-60,000$3.48M$4.74M0.43%+$1.26M
Tigo Energy, Inc.(TYGO)7,280,3121,990,371-5,289,941$27.37M$4.64M0.42%-$22.74M
Energous Corporation(WATT)215,000182,000-33,000$3.37M$4.38M0.40%+$1.00M
RenovoRx, Inc.(RNXT)3,706,1974,405,439+699,242$3.68M$4.32M0.39%+$635.6K
Richardson Electronics, Ltd.(RELL)0200,434+200,434$0$3.81M0.34%+$3.81M
NeurAxis, Inc.(NRXS)400,000519,938+119,938$2.96M$3.80M0.34%+$840.7K
Coya Therapeutics, Inc.(COYA)975,404631,912-343,492$3.84M$3.70M0.33%-$146.4K
INVE Technologies, Inc.(INVE)409,1861,449,121+1,039,935$1.51M$3.65M0.33%+$2.14M
Elutia Inc.CL A(ELUT)3,595,2502,695,644-899,606$3.78M$2.64M0.24%-$1.13M
Aprea Therapeutics, Inc.(APRE)1,015,5411,015,5410$774.8K$814.8K0.07%+$40.0K
Biofrontera Inc.(BFRI)915,210739,910-175,300$740.4K$699.6K0.06%-$40.8K
Quoin Pharmaceuticals, Ltd.ADS(QNRX)51,00070,000+19,000$336.6K$338.8K0.03%+$2.2K
NN, Inc.(NNBR)011,496+11,496$0$41.3K0.00%+$41.3K
BK Technologies Corporation(BKTI)32,6150-32,615$2.43M$0—-$2.43M
Esperion Therapeutics Inc Ne4,400,0000-4,400,000$12.06M$0—-$12.06M
Generac Holdings Inc.(GNRC)90,0000-90,000$17.58M$0—-$17.58M
Intellicheck, Inc.(IDN)1,517,2490-1,517,249$10.61M$0—-$10.61M
Larimar Therapeutics, Inc.(LRMR)3,000,0000-3,000,000$13.50M$0—-$13.50M
LightPath Technologies, Inc.CL A(LPTH)100,0000-100,000$1.00M$0—-$1.00M
Lipocine Inc.(LPCN)200,0000-200,000$1.60M$0—-$1.60M
nLIGHT, Inc.(LASR)340,0000-340,000$19.39M$0—-$19.39M
Protara Therapeutics, Inc.(TARA)1,622,7330-1,622,733$8.45M$0—-$8.45M
Regal Rexnord Corporation(RRX)75,0000-75,000$14.04M$0—-$14.04M
Regentis Biomaterials Ltd.(RGNT)300,0000-300,000$916.5K$0—-$916.5K
SmartKem, Inc.(SMTK)895,4490-895,449$203.7K$0—-$203.7K
Zebra Technologies CorporationCL A(ZBRA)100,0000-100,000$20.91M$0—-$20.91M
Zevra Therapeutics, Inc.(ZVRA)1,200,0000-1,200,000$11.18M$0—-$11.18M
Page 1 of 1
AIGH Capital Management LLC — 13F Holdings — Q2 2026 | TickerTrail